Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven N Reske

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
European Urology|September 28, 2010
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancerMaria Picchio, Alberto Briganti, Stefano Fanti, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapyChangxian Shen, Dirk Rattat, Andreas Buck, et al.
Neurosurgical Review|May 30, 2018
Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and <sup>11</sup>C-methionine positron emission tomography in resection of glioblastoma: a prospective studyAndrej Pala, Sven N Reske, Nina Eberhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Cancer Research|May 17, 2003
3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human diseaseMartin Wagner, Ulrike Seitz, Andreas Buck, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferationInga Buchmann, Andreas T J Vogg, Gerhard Glatting, et al.
Neuroimage|April 22, 2008
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET studyAndrea G Ludolph, Jan Kassubek, Klaus Schmeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2006
Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass graftsJochen Wöhrle, Bernd Joachim Krause, Thorsten Nusser, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
European Urology|September 28, 2010
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancerMaria Picchio, Alberto Briganti, Stefano Fanti, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapyChangxian Shen, Dirk Rattat, Andreas Buck, et al.
Neurosurgical Review|May 30, 2018
Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and <sup>11</sup>C-methionine positron emission tomography in resection of glioblastoma: a prospective studyAndrej Pala, Sven N Reske, Nina Eberhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Cancer Research|May 17, 2003
3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human diseaseMartin Wagner, Ulrike Seitz, Andreas Buck, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferationInga Buchmann, Andreas T J Vogg, Gerhard Glatting, et al.
Neuroimage|April 22, 2008
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET studyAndrea G Ludolph, Jan Kassubek, Klaus Schmeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2006
Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass graftsJochen Wöhrle, Bernd Joachim Krause, Thorsten Nusser, et al.
Pageof 9